Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K/A, Date: 2011-05-19
Original SEC Filing: Click here

---

Webplus: BSPM/20110519/10-K.A/1/000.htm SEC Original: biostarpharma10ka123110.htm
FORM 10-K /A Amendment No. 1 (Mark One) x December 31, 2010 For the fiscal year ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province

---

---

Webplus: BSPM/20110519/10-K.A/2_EX-23.1/000.htm SEC Original: ex23-1.htm
Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8 (No. 333-161598) of Biostar Pharmaceuticals, of our reportted March 24, 2011 relating to thensolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar

---

---

Webplus: BSPM/20110519/10-K.A/3_EX-31.1/000.htm SEC Original: ex31-1.htm
CERTIFICATION I, Ronghua Wang, certify that: 1. R I have reviewed this Annual 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

---

---

Webplus: BSPM/20110519/10-K.A/4_EX-31.2/000.htm SEC Original: ex31-2.htm
CERTIFICATION I, Zack Pan, certify that: 1. R I have reviewed this Annual 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

---

---

Webplus: BSPM/20110519/10-K.A/5_EX-32.1/000.htm SEC Original: ex32-1.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 5 EX-32.1

---

---

Webplus: BSPM/20110519/10-K.A/6_EX-32.2/000.htm SEC Original: ex32-2.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 6 EX-32.2

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K/A, Date: 2011-05-19CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046